Essity stock (SE0009922164): Goldman Sachs trims target as short interest stays in focus

Goldman Sachs lowered its price target on Essity to SEK 260 from SEK 265 and kept a Neutral rating, while new public short-selling data adds a fresh layer of attention on the Swedish hygiene group.

Essity shares are back on traders’ screens after Goldman Sachs cut its price target to SEK 260 from SEK 265 and reiterated a Neutral rating, according to MarketScreener / BN as of 05/19/2026. The stock closed at 252.50 SEK, leaving the new target only modestly above the last quoted level, a detail that matters for US investors following the Stockholm-listed consumer staples name.

Short-selling disclosure is also part of the latest setup. MarketScreener reported that Millennium International Management emerged as a new public short seller after increasing its position to 0.5% of share capital, taking total public short positions in Essity to 3.18%, according to MarketScreener / FI data as of 05/19/2026. The company is relevant beyond Sweden because it sells hygiene products used in households, hospitals, and workplaces across Europe and other developed markets that often feed into global consumer-demand trends watched by US investors.

As of: 19.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Essity AB
• Sector/industry: Consumer staples, hygiene products
• Headquarters/country: Sweden
• Core markets: Europe, North America, selected emerging markets
• Key revenue drivers: Tissue, personal care, and professional hygiene products
• Home exchange/listing venue: Nasdaq Stockholm (ticker: ESSITY B)
• Trading currency: SEK

Essity stock: core business model

Essity is a global hygiene and health company whose portfolio includes toilet paper, paper towels, feminine care, incontinence care, and professional hygiene products. Its scale and consumer-staples profile make it a defensive holding in many international portfolios, and that can matter to US investors looking for exposure outside the domestic market.

The group’s business is relatively broad, but it still depends on pricing power, raw-material costs, and demand stability in everyday products. That combination often leads investors to focus on margin trends, cost inflation, and management’s ability to protect profitability when volumes are steady but input costs move around.

Main revenue and product drivers for Essity

Essity’s largest product families are paper hygiene products and personal care items, with professional hygiene also contributing to the mix. In practical terms, revenue can be driven by household consumption, public-sector and healthcare demand, and commercial cleaning usage, which helps explain why the stock often trades as a steady but news-sensitive consumer name.

For US-based readers, the key point is that Essity is not a high-beta growth story. It is a mature, internationally diversified business whose share performance tends to reflect earnings revisions, analyst changes, and sentiment around margins more than headline growth. That makes the current Goldman Sachs note and the short-position disclosure especially relevant as near-term catalysts.

The latest analyst move does not by itself change the company’s fundamentals, but it does create a fresh reference point for market expectations. When a major bank trims a target and keeps a neutral stance, investors often read it as a sign that near-term upside is viewed as limited unless operating results improve or sentiment shifts.

Short-interest data can also influence trading even when the underlying business is stable. A higher public short position does not prove a negative outcome, but it signals that some market participants are positioning for weaker performance or slower margin recovery. For a widely held consumer staple, that can amplify attention around each new earnings release or guidance update.

Conclusion

Essity remains a defensive consumer-staples name with global reach, but the latest analyst target cut and the newly reported public short position show that sentiment is not entirely calm. The stock’s next direction will likely depend on whether the company can support margins and maintain steady demand across its hygiene categories. For US investors, the case is less about fast growth and more about earnings resilience, valuation discipline, and how European consumer trends evolve.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.